Papers matching “selection trials” in Inflammatory Bowel Disease 40
Not finding it? Sign in to also search OpenAlex live.
-
Efficacy and safety of filgotinib as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a post-hoc analysis of the phase 2b/3 SELECTION trial2022 Intestinal Research article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Toshifumi Hibi∥, Satoshi Motoya, Tadakazu Hisamatsu, Fumihito Hirai, Kenji Watanabe, Katsuyoshi Matsuoka, +10 more
15citations -
Rapid and Sustained Symptom Relief in Patients With Ulcerative Colitis Treated With Filgotinib: Data From the Phase 2b/3 SELECTION Trial2022 The American Journal of Gastroenterology article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access cited by 1 patent
Silvio Danese, Marc Ferrante, Brian G. Feagan, Laurent Peyrin‐Biroulet, Toshifumi Hibi∥, William J. Sandborn, +10 more
31citations -
Factors associated with response to filgotinib and the prognostic power of faecal calprotectin for ulcerative colitis in the phase 2b/3 SELECTION trial2025 Digestive and Liver Disease article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Edouard J. Louis, Stefan Schreiber, Tadakazu Hisamatsu, Toshifumi Hibi∥, Corinne Jamoul, Karine Muller, +4 more
0citations -
POSA350 Effect of Filgotinib on EQ-5D-5L and Work Productivity and Activity Impairment Among Patients with Ulcerative Colitis: Results from the Phase 2B/3 Selection Trial2022 Value in Health article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Silvio Danese, Brian G. Feagan, Stefan Schreiber, Ken Hasegawa, X. L.U., Alessandra Faria Oortwijn, +2 more
1citations -
Filgotinib Improved Health-Related Quality of Life and Led to Comprehensive Disease Control in Individuals with Ulcerative Colitis: Data from the SELECTION Trial2023 Journal of Crohn s and Colitis article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Stefan Schreiber, Brian G. Feagan, Laurent Peyrin‐Biroulet, Severine A.R.A. Vermeire, Margaux Faes, Alessandra Faria Oortwijn, +3 more
18citations -
OP07 Exploring disease control by combining clinical, biological, and health-related quality of life remission with endoscopic improvements among Ulcerative Colitis patients treated with filgotinib: A post-hoc analysis from the SELECTION trial2022 Journal of Crohn s and Colitis article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Stefan Schreiber, Brian G. Feagan, Laurent Peyrin‐Biroulet, Severine A.R.A. Vermeire, Margaux Faes, Alessandra Faria Oortwijn, +3 more
5citations -
P772 Comprehensive disease control in patients with Ulcerative Colitis: refinement of a multi-component endpoint using data from the filgotinib SELECTION trial2024 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Stefan Schreiber, Brian G. Feagan, Severine A.R.A. Vermeire, Silvio Danese, Veerle Vyncke, Margaux Faes, +2 more
0citations -
P736 Factors associated with partial Mayo Clinic Score over time in patients with Ulcerative Colitis treated with filgotinib in the phase 2b/3 SELECTION trial2023 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Laurent Peyrin‐Biroulet, E Louis, Tadakazu Hisamatsu, C Jamoul, Eva Santermans, K Harris, +2 more
0citations -
Efficacy of Filgotinib in Patients with Ulcerative Colitis by Line of Therapy in the Phase 2b/3 SELECTION Trial2023 Journal of Crohn s and Colitis article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Iris Dotan, Brian G. Feagan, Virginia Taliadouros, Alessandra Faria Oortwijn, Christine Rudolph, Angela de Haas, +4 more
10citations -
OP25 Efficacy of filgotinib in patients with Ulcerative Colitis by line of therapy in the phase 2b/3 SELECTION trial2021 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease
Laurent Peyrin‐Biroulet, Iris Dotan, Toshifumi Hibi∥, Virginia Taliadouros, Alessandra Faria Oortwijn, Sally Zhao, +3 more
2citations -
Long‐term safety and efficacy of filgotinib for the treatment of moderately to severely active ulcerative colitis: Interim analysis from up to 4 years of follow‐up in the SELECTION open‐label long‐term extension study2024 Alimentary Pharmacology & Therapeutics article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Brian G. Feagan, Katsuyoshi Matsuoka, Gerhard Rogler, David Laharie, Severine A.R.A. Vermeire, Silvio Danese, +9 more
14citations -
P56 Prolonged benefit of filgotinib in patients with ulcerative colitis in SELECTION2023 Poster presentations conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease
Ian Beales, David Laharie, Andreas Sturm, Taku Kobayashi, Takayuki Matsumoto, Alessandra Faria Oortwijn, +4 more
0citations -
Distinct trajectories of symptomatic response in ulcerative colitis during filgotinib therapy: A post hoc analysis from the SELECTION study2024 United European Gastroenterology Journal article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Stefan Schreiber, Brian G. Feagan, Edouard J. Louis, Tadakazu Hisamatsu, Toshifumi Hibi∥, Louis Dron, +5 more
9citations -
Filgotinib induction-study baseline characteristics of patients with ulcerative colitis who achieve sustained corticosteroid-free remission: post hoc analysis of the phase 2b/3 SELECTION study2024 Intestinal Research article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Taku Kobayashi, Axel U Dignass, Xavier Roblin, Yoshie Takatori, Toshihiko Kaise, Alessandra Faria Oortwijn, +2 more
2citations -
P45 Combining clinical, biological, and health-related quality of life remission with endoscopic improvements: data from SELECTION2022 Poster presentations conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease
Ben Morison, Stefan Schreiber, Brian G. Feagan, Laurent Peyrin‐Biroulet, Severine A.R.A. Vermeire, Margaux Faes, +4 more
0citations -
OMO-2 Filgotinib efficacy in patients with ulcerative colitis by line of therapy: Phase 2b/3 selection results2021 conference-paper Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Ben Morison, Laurent Peyrin‐Biroulet, Iris Dotan, Toshifumi Hibi∥, Virginia Taliadouros, Alessandra Faria Oortwijn, +4 more
0citations -
P57 Predicting late responders to filgotinib in patients with ulcerative colitis: a post hoc analysis of SELECTION and SELECTIONLTE2023 Poster presentations conference-paper Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease
Ian Beales, Katsuyoshi Matsuoka, Mark Löwenberg, Mathurin Fuméry, Yoshie Takatori, Yasushi Fujitani, +4 more
0citations -
A Prediction Model for Successful Increase of Adalimumab Dose Intervals in Patients with Crohn’s Disease: Secondary Analysis of the Pragmatic Open-Label Randomised Controlled Non-inferiority LADI Trial2024 Digestive Diseases and Sciences article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Reinier C A van Linschoten, Fenna M. Jansen, Renske W. M. Pauwels, Lisa J. T. Smits, Femke Atsma, Wietske Kievit, +22 more
2citations -
P678 Long-term efficacy, safety and health-related quality of life in patients who achieved comprehensive disease control with filgotinib in SELECTION: analysis of ~3 years in SELECTIONLTE2024 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
B G Feagan Senior Scientific Officer, Katsuyoshi Matsuoka, Gerhard Rogler, David Laharie, Severine A.R.A. Vermeire, Silvio Danese, +8 more
0citations -
Mediators of Filgotinib Treatment Effects in Ulcerative Colitis: Exploring Circulating Biomarkers in the Phase 2b/3 SELECTION Study2024 Inflammatory Bowel Diseases article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access cited by 2 patents
Hiroshi Nakase, Silvio Danese, Walter Reinisch, Timothy E. Ritter, Yan Liang, Emily Wendt, +10 more
5citations -
P393 Effect of filgotinib on anaemia in patients with Ulcerative Colitis in SELECTION2023 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Roberta Loveikyte, Alessandra Faria Oortwijn, B Eskens, C Jamoul, K. Muller, A van der Meulen-de Jong
3citations -
P690 Prolonged benefit of filgotinib in patients with Ulcerative Colitis in SELECTION2023 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
David Laharie, A Sturm, Taku Kobayashi, Takayuki Matsumoto, Alessandra Faria Oortwijn, C Jamoul, +2 more
1citations -
Corticosteroid-Sparing Effects of Filgotinib in Moderately to Severely Active Ulcerative Colitis: Data from the Phase 2b/3 SELECTION Study2022 Journal of Crohn s and Colitis article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Edward V. Loftus, Severine A.R.A. Vermeire, Brian G. Feagan, Franck‐Olivier Le Brun, Alessandra Faria Oortwijn, Ulrik Moerch, +2 more
12citations -
Withdrawal and Re-treatment with Filgotinib in Ulcerative Colitis: Post Hoc Analyses of the Phase 2b/3 SELECTION and SELECTIONLTE Studies2023 Journal of Crohn s and Colitis article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Severine A.R.A. Vermeire, Brian G. Feagan, Laurent Peyrin‐Biroulet, Alessandra Faria Oortwijn, Margaux Faes, Angela de Haas, +1 more
7citations -
P551 Benefit–risk trade-offs and patient preferences for therapy selection in Ulcerative Colitis: a multi-country preference study2024 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Javier P. Gisbert, Stefan Schreiber, Corey Allan Siegel, Fernando Magro, Anna Jus, Chiara L. Whichello, +4 more
1citations